DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20174316

Hypothyroidism in surgically treated T4 hypopharyngeal and laryngeal cancers

Deepak Janardhan, Bipin T. Varghese, Elizabeth Mathew Iype, Shaji Thomas

Abstract


Background: Total laryngectomy in laryngohypopharyngeal cancers, both in primary setting and salvage scenario, include variable amounts of thyroid resection. Although considerable proportion of these cases undergo total thyroidectomy, with an intention of wider surgical clearance, histopathological examination for thyroid infiltration, very often indicate that such resections are generally out of proportion to the actual oncological requirement.

Methods: Forty three patients undergoing total laryngectomy with no prior thyroid dysfunction, from April 2014 to 2016, at our centre, were prospectively studied for post treatment, thyroid function with tests done at 6th month. Overt and occult hypothyroidism was correlated with extent of thyroid preserved intraoperatively.  

Results: Of 43 patients studied, 82% had extralaryngeal spread, and 16% of them showed thyroid gland infiltration. Only 7% were patholog1ically correlated for gland infiltration. Among those who had hemithyroidectomy, clinical hypothyroidism was seen in 20% primary and 85% salvage cases by 6th month of post treatment period.

Conclusions: In clinicoradiologically favourable scenarios, thyroid preservation attempt helps to augment the neopharynx closure line and to preserve the parathyroids. Anatomical preservation however doesnot guarantee thyroid function, which needs regular follow up to avoid post-operative complications and better QOL.


Keywords


Hypothyroidism, Total laryngectomy/pharyngolaryngectomy, Chemotherapy, Radiotherapy

Full Text:

PDF

References


Banipal RPS, John M, Mahajan MK, Uppal B. Thyroid diseases as a sequelae following treatment of head and neck cancer. Indian J Cancer. 2011;48(2):194-8.

Ogura J. Surgical pathology of cancer of the larynx. Laryngoscope. 1955;65:867–926.

Brennan AJ, Meyers AD, Jafek BW. The intraoperative management of the thyroid gland during laryngectomy. Laryngoscope. 1991;101:929–34.

Yeager VL, Archer CR. Anatomical routes for cancer invasion of laryngeal cartilages. Laryngoscope. 1982;92:449–52.

Strome S, Robey T, Devancy K, Krause C, Hogikyan N. Subglottic carcinoma: review of a series and characterization of its patterns of spread. Ear Nose Throat J. 1999;78:622–32.

Sparano A, Chernock R, Laccourreye O, Weinstein G, Feldman M. Predictors of thyroid gland invasion in glottic squamous cell carcinoma. Laryngoscope. 2005;115:1247–50.

Daddas B, Berna U, Cakir B, Ozdogan H, Batur A, Turgut S. Intraoperative management of the thyroid gland in laryngeal cancer surgery. J Otolaryngol. 2001;30:179–83.

Buckley JG, MacLennan K. Cancer spread in the larynx: a pathologic basis for conservation surgery. Head Neck Surg. 2000;22:265–74.

Reidenback MM. The paraglottic space and transglottic cancer: anatomical considerations. Clin Anat. 1996;4:244–51.

Harrison DF. Thyroid gland in the management of laryngopharyngeal cancer. Arch Otolaryngol. 1973;97:301–302.

Mohr RM, Quenelle J, Shumrick DA. Vertico-frontolateral laryngectomy (hemilaryngectomy). Arch Otolaryngol. 1983;109:384–95.

Chen SA, Muller S, Chen AY, Hudgins PA, Shin DM, Khuri F, Saba NF, Beitler JJ.Patterns of extralaryngeal spread of laryngeal cancer: thyroid cartilage penetration occurs in a minority of patients with extralaryngeal spread of laryngeal squamous cell cancers. Cancer. 2011;117(22):5047-51.

Sinard RJ, Tobin EJ, Mazzaferri EL, Hodgson SE, Young DC, Kunz AL, et al. Hypothyroidism After Treatment for Nonthyroid Head and Neck Cancer. Arch Otolaryngol Head Neck Surg. 2000;126(5):652-7.

Liening DA, Duncan NO, Blakeslee DB, Smith DB. Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg. 1990;10310-3.

Turner SL, Tiver KW, Boyages SC. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 1995;31279- 83.

Harrison DF. Significance and means by which laryngeal cancer invades thyroid cartilage. Ann Otol Rhinol Laryngol. 1984;93:293–6.

Kim JW, Han GS, Byun SS, Lee DY, Cho BH, Kim YM. Management of thyroid gland invasion in laryngopharyngeal cancer. Auris Nasus Larynx. 2008;35:209-12.

Buisset E, Leclerc L, Lefebvre JL, Stern J, Ton-Van J, Gosselin P, et al. Hypothyroidism following combined treatment for hypopharyngeal and laryngeal carcinoma. Am J Surg. 1991;162:345–7.

Donnelly MJ, O’Meara N, O’Dwyer TP. Thyroid dysfunction following combined therapy for laryngeal carcinoma. Clin Otolaryngol Allied Sci. 1995; 20:254–7.

Palmer BV, Gaggar N, Shaw HJ. Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx. Head Neck Surg. 1981;4:13–5.

Arem R, Patch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism: effect of levothyroxine therapy. Arch Intern Med. 1990;150:2097-100.

Series JJ, Biggart EM, O'Reilly DS, Packard CJ, Shepherd J. Thyroid dysfunction and hyper-cholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta. 1988;172(2-3):217-21.